ArticleInternational journal of molecular sciences2020

Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines.

Reina Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.